CCR2 and neoplasm: made a significant finding demonstrating that targeting the CCL2/CCR2 axis therapeutically could effectively impede the recruitment of inflammatory monocytes, inhibit tumor-associated macrophage (TAM) infiltration, and reverse M2 polarization.